In a new study of more than 125,000 pregnant women in Sweden, researchers found that the risk of hepatobiliary cancer and immune - mediated and cardiovascular diseases later in life is higher in women
with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
The serum liver enzyme activity (ALP, ALT, and AST) is normal to mildly (two or three times) increased consistent
with a lesion of hepatic atrophy and minimal hepatocellular injury or
intrahepatic cholestasis.